Assoc. Prof. Dr. Esra Turan Erkek

Thrombopénie

Troubles hémorragiques

Troubles thrombotiques

Lymphome

Leucémie chronique

Maladies myéloprolifératives

Myélome multiple

Anémie

22 mars 2024 — Professorat associé

2011–2014 — Faculté de médecine d’Istanbul de l’Université d’Istanbul, département de médecine interne, unité d’hématologie, Istanbul

2005–2010 — Hôpital de formation et de recherche Dr Lütfi Kırdar de Kartal, clinique de médecine interne, Istanbul

1998–2004 — Faculté de médecine de l’Université Uludağ, Bursa

2015–2026 — Hôpital municipal Dr Lütfi Kırdar d’Istanbul

2010 — Hôpital public de Hakkari, service obligatoire en médecine interne

25e formation pratique en cytométrie en flux, Istanbul, 17–21 juin 2019 (nationale)

Formation J&J GCO Investigator Rave, version 3.0, Medidata University, 21 septembre 2012 (internationale)

Cours d’oncologie hématologique et de greffe de moelle osseuse, Chypre, 7–9 février 2014 (national)

Cours de la 3e conférence internationale sur le myélome multiple, Milan, Italie, 7–9 octobre 2016 (international)

Mini-académie de cytométrie en flux de la Société turque d’hématologie (THD), 2026

Formation ITP Bite-Class de la Société turque d’hématologie (THD), 2025

Evre 1 ve Evre 2 Kronik Böbrek Yetersizliğinin Dipper ve Non Dipper Kan Basıncı Paterni Gelişimine Etkisi (2010) Tez Danışmanı Prof Dr Zerrin Bicik Bahçebaşı

Yan Dal Uzmanlık Tezi : Paroksismal Noktürnal Hemoglobinüri ve Aplastik Anemi Olgularında Doaşan Endotel Hücreleri ve Tromboza Etkisi( 2014) Tez Danışmanı ( Prof Dr Mustafa N Yenerel)

Sahin F, Saydam G, Cömert M, Uz B, Yavuz AS, Turan E, Yönal I, Atay H, Keltikli E, Turgut M, Pehlivan M, Akay MO, Gürkan E, Paydaş S, Kahraman S, Demirkan F, Kırkızlar O, Akpınar S, Pamuk GE, Demir M, Ozbaş HM10, Sönmez M10, Gültürk M, Salihoğlu A, Eşkazan AE, Ar C, HaydaroğluŞahin H, Ongören S, Başlar Z, Aydın Y, Yenerel MN, Tüzüner N, Ferhanoğlu B, Haznedaroglu IC, Ilhan O, Soysal T.Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients.Turk J Haematol. 2013 Dec;30(4):351-8. doi: 10.4274/tjh.2013.0151. Epub 2013 Dec 5

TuranErkekE,Kalayoglu-BesısıkS.An Unexpected Innocent Complication Associated with Azacitidine Treatment of Myelodysplastic Syndrome: Erythema Annulare Centrifugum .Turk J Haematol. 2016 Mar 5;33(1):81-2. doi: 10.4274/tjh.2015.0268

Turan Erkek E, Karaali CN, Yılmaz G, Gültürk E. Bleomycin-Induced Flagellate Dermatitis. Turk J Haematol. 2019 May 3;36(2):138-140. doi: 10.4274/tjh.galenos.2019.2018.0317. Epub 2019 Jan 2. PMID: 30600679; PMCID: PMC6516091.

Beyhan Sagmen S, Comert S, Turan Erkek E, Küçüköz Uzun A, Doğan C, Yılmaz G, Kıral N, Fidan A, Yılmaz Haksal Ç, Torun Parmaksız E. Can We Predict Bleomycin Toxicity with PET-CT? Acta Haematol. 2019;142(3):171-175. doi: 10.1159/000502374. Epub 2019 Aug 27. PMID: 31454795.

Dogan EE, Turan Erkek E, Elverdi T, Celik Kamaci S, Ciftci U, Demirel N, Aydin D, Eren R. Eltrombopag in the Treatment of Immune Thrombocytopenia: Two-Center Experience from Istanbul. Indian J Hematol Blood Transfus. 2022 Apr;38(2):327-332. doi: 10.1007/s12288-021-01462-5. Epub 2021 Jul 5. PMID: 35496971; PMCID: PMC9001770..

Erkek ET, Nazligul E, Nalcaci M, Yenerel MN. Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia. Indian J Hematol Blood Transfus. 2022 Apr;38(2):319-326. doi: 10.1007/s12288-021-01445-6. Epub 2021 May 26. PMID: 35496969; PMCID: PMC9001756.

Uğur MC, Namdaroğlu S, Doğan EE, Turan Erkek E, Nizam N, Eren R, Bilgir O. Comparison of Splenectomy and Eltrombopag Treatment in the Second-Line Treatment of Immune Thrombocytopenic Purpura. Turk J Haematol. 2021 Aug 25;38(3):181-187. doi: 10.4274/tjh.galenos.2021.2021.0216. Epub 2021 Jun 24. PMID: 34162173; PMCID: PMC8386313.

Turan Erkek E, Aslan E. Additional malignancies shorten overall survival in chronic lymphocytic leukemia irrespective of chromosomal aberrations: A retrospective cohort study. Medicine (Baltimore). 2023 Feb 10;102(6):e32906. doi: 10.1097/MD.0000000000032906. PMID: 36820600; PMCID: PMC9907968.

Turan Erkek E, Tahtalı T. Co-occurrence of multiple thrombophilic factors with a popliteal artery embolism history: an extraordinary myelofibrosis case. Kuwait Medical Journal, September 2022 Vol 54 No:3 , 405-408

Erkek, ET; Isik, AC1; Ipek, Y; Kul, AN. Tyrosine Kinase Inhibitor Therapies in Chronic Myeloid Leukemia: Effects on Clinical Characteristics and Triglyceride-to-High Density Lipoprotein Cholesterol Ratio. Nigerian Journal of Clinical Practice 26(6):p 802-809, June 2023. | DOI: 10.4103/njcp.njcp_755_22

Tuna, MK; Erkek, ET. Is Immune Thrombocytopenia and its Treatment Associated with Sarcopenia?. Nigerian Journal of Clinical Practice 27(2):p 180-187, February 2024. | DOI: 10.4103/njcp.njcp_41_23

Doğan EE, Keklik Karadağ F, Aydin D, DemirelN, Sağlam S, Davulcu EA,Turan Erkek E, Eren R, Akad Soyer N; Şahin F, Saydam G. "The assessment of health-related quality of life in patients with polycythemia vera." Medicine 103.30 (2024): e38814. DOI: 10.1097/MD.0000000000038814

Ogret Y, Erkek E, OsmanbasogluE,Yonal İ, SavranOguz F, Nalcacı M, Yavuz AS, KalayogluBesısık S. Restoring of donor chimerism by thyrosine kinase inhibitor treatment in relapsed chronic myeloid leukemia after allogeneic transplantation . Tissue Antigens Volume 84, Number 1 July 2014

Turan Erkek E, Demir N, Ozkan G, Yavuz AS. Testicular and CutaneousRelapse in Acute Promyelocytic Leukemia Treated with All-trans Retinoic Acid and Chemotherapy. Eurasian Journal of Medicine and Oncology. Volume 1, Issue 1,2017.doi: 10.14744/ejmo.2017.87597 Pages 53-54

Cetinkaya Esen H, Gulturk E, Turan Erkek E, Ustaoglu M. Etiological Investigation Of Patients Visiting A Hematology Polyclinic For Anemia. EJMI. 2019; 3(3): 173-181

Turkmen Bekmez E, Volkan O, Demir N, Turan Erkek E, Ataman Tasan D, Aliustaoglu M. Relationship Between Rheumatoid Arthritis Activation Criteria and Serum Hepcidin Levels. EJMI. 2019; 3(4): 275-279

Turan Erkek E, Akın S, Ozgur Y, Aydın Z, Bicik Z. Comparison of DipperandNon-DipperHypertensionPatternsAccordingtoChronicKidneyDiseaseStage. Journal Of NephrologyAdvancesVol No:1 İssue2: 15-23 September 2019DOI: 10.14302/issn.2574-4488.jna-19-3008

Alp Posteki E, Turan Erkek E,Posteki G, Erkek A, Aliustaoglu M. The Correlation Between Systemic Inflammatory ResponseandSurvival in Patients with Metachronous and Synchronous Liver Metastatic Colorectal Cancer. Eurasian Journal of Medical İnvestigation.Volume:4 İssue:1-2020;4(1):17–23/ DOI:10.14744/ejmi.2019.18112

Doğan EE, Demirel N, Turan Erkek E, Aydın D, Mansuroğlu İ, Cömert Özkan M, Eren R. Treatment Outcomes in Hairy Cell Leukemia: Data of Patients in a Tertiary Referral Hospital in Turkey for Over 20 Years. Med J Bakirkoy 2021;17:320-326. 10.4274/BMJ.galenos.2021.85047

Dogan, E. E., Karadag, F. K., Aydin, D., Demirel, N., Davulcu, E. A., Erkek, E. T., ... & SAYDAM, G. (2021). The Effect of Serum Lactate Dehydrogenase (LDH) Level on the Response to Erythropoiesis Stimulating Agents in Patients with Low and Intermediate Risk Myelodysplastic Syndrome. Journal of Haematology and Stem Cell Research, 1(2), 89-97.

Turan Erkek E, Demir N , Erdem S, Ozkan G, Arslan O, Kalayoglu Besısık S.Erdheim–Chester disease: a single center experience. Hematology Transfusion and Cell Therapy 42:59-60.October 2020 DOI: 10.1016/j.htct.2020.09.107. LicenseCC BY-NC-ND 4.0

Evman, Melis Demirag, and Esra Turan Erkek. "Does Chronic Immune Thrombocytopenia Lead to Hearing Loss?." Medical Science and Discovery 9.10 (2022): 577-580.

Ipek Y, Erkek ET. Hematological Malignancies in the Coronavirus Disease-2019 Era: Evaluation of Patient Outcomes and the Reasons for Vaccination Hesitation. jms [Internet]. 2022Nov.24 [cited 2023Jan.9];25(4